Lord’s Mark Industries Ltd. has launched the Renalyx Machine, a fully integrated, AI-powered renal care ecosystem, at Shakti Super Speciality Hospital in Ahmedabad, Gujarat, India. This innovative hemodialysis system combines AI clinical intelligence, operational management, and remote patient monitoring, marking a significant advancement in dialysis care. The Renalyx Machine is part of a three-layer ecosystem that includes the RenalOS platform for real-time monitoring and the Aureoon operational model, enabling hospitals to manage dialysis centres without capital investment. With plans to establish 50 managed dialysis centres across India by March 2027, the initiative aims to make renal treatment more accessible and affordable, particularly in underserved regions. Lord’s Mark is also pursuing US FDA approval for the Renalyx Machine, emphasizing India's potential as a global hub for advanced dialysis technology. According to Sachidanand Upadhyay, Managing Director & CEO of Lord’s Mark, this launch represents a commitment to addressing critical challenges in renal care through intelligent technology and indigenous manufacturing.